Skip to main content
. 2022 Feb 2;150:e43. doi: 10.1017/S0950268822000176

Table 2.

Summarised results of included studies

Indicators No. of studies Sample size Effect size (95%CI) Model Heterogeneity (%)
I2 P
Clinical features
Persistent chest pain 10 1517 2.07 (1.00–4.27) Random 82.5 <0.001
Chest distress 2 240 1.62 (0.92–2.82) Fixed 0.0 1.000
Haemoptysis 8 1379 0.92 (0.44–1.91) Random 86.5 <0.001
Fever 8 1056 0.78 (0.47–1.31) Random 69.8 0.002
Emaciation 7 954 1.69 (0.93–3.06) Random 72.1 0.001
Shortness of breath 2 240 1.22 (0.74–2.03) Fixed 0.0 1.000
Cervical lymphadenectasis 4 538 1.02 (0.71–1.46) Fixed 0.0 0.657
Irritable cough 11 1695 2.43 (1.43–4.11) Random 81.7 <0.001
Nigh sweating 7 970 0.56 (0.36–0.87) Random 51.4 0.054
Dyspnoea 3 406 3.58 (1.01–12.72) Random 62.2 0.071
Bloody sputum 5 596 1.46 (1.02–2.10) Fixed 0.0 0.697
Haemorrhagic pleural effusion 5 921 5.73 (1.63–20.12) Random 84.6 <0.001
Radiologic features
Calcified shadow 7 982 1.93 (0.51–7.25) Random 91.9 <0.001
Mass shadow 5 1015 7.26 (0.86–61.03) Random 96.8 <0.001
Lobulation sign 7 902 7.67 (3.49–16.84) Random 79.2 <0.001
Mass 3 264 11.94 (5.74–24.84) Fixed 30.6 0.236
Nodular shadow 5 586 4.92 (2.79–8.66) Fixed 14.5 0.322
Satellite lesion 4 408 9.29 (2.86–30.18) Random 75.1 0.007
Small vacuole sign 2 168 5.07 (1.31–19.66) Random 59.0 0.118
Vacuole sign 3 414 7.86 (3.40–18.16) Fixed 0.0 0.984
Spicule sign 9 1180 6.66 (4.85–9.16) Fixed 0.0 0.825
Pleural indentation 5 568 3.18 (2.14–4.73) Fixed 0.0 0.561
Cord-like shadow 5 598 0.21 (0.13–0.33) Fixed 0.0 0.954
Cavitary lesions 12 1767 0.30 (0.23–0.38) Fixed 0.0 0.981